Related Experiment Videos
Immunoreactive circulating alpha-interferon is low in Sjögren's syndrome
S Shiozawa1, K Shiozawa, S Shimizu
1Department of Medicine, Kobe University School of Medicine, Japan.
British Journal of Rheumatology
|February 1, 1990
Summary
Patients with Sjögren's syndrome exhibit significantly lower circulating alpha-interferon levels compared to healthy individuals. This suggests an impaired ability in Sjögren's syndrome patients to maintain adequate alpha-interferon levels.
Area of Science:
- Immunology
- Rheumatology
- Biochemistry
Background:
- Sjögren's syndrome is an autoimmune disease affecting exocrine glands.
- Alpha-interferon plays a crucial role in immune regulation and antiviral responses.
Purpose of the Study:
- To investigate circulating alpha-interferon levels in patients with Sjögren's syndrome.
- To compare these levels with those in age- and sex-matched healthy subjects.
Main Methods:
- Plasma samples were collected from 26 patients with Sjögren's syndrome.
- Alpha-interferon concentrations were measured using a validated assay.
- Levels were compared to a control group of healthy subjects.
Main Results:
- Circulating alpha-interferon levels in Sjögren's syndrome patients were significantly lower (0.069 ng/ml) than in healthy controls (0.119 ng/ml).
- The difference was statistically significant (P < 0.01).
Conclusions:
- Sjögren's syndrome patients demonstrate a reduced capacity to maintain circulating alpha-interferon.
- This finding may have implications for understanding the pathogenesis and potential therapeutic strategies in Sjögren's syndrome.